CSL Behring
Last update: August 26, 2019
Biotechnology
United States (USA)
Its 19 main executivesIts 6 subsidiaries
Recent executive movements at CSL
Paul McKenzie will join the company as Chief Operating Officer on Jun. 3, 2019 (news posted on May 17 2019).
Create an alert
to follow the executive moves at CSL Behring.
Latest M&A news in Biotechnology.
WebMD Health has announced the acquisition of Aptus Health (posted on Sep 30, 2019).
Castle Creek Pharmaceuticals has announced the acquisition of Fibrocell Science (posted on Sep 13, 2019).
Medicine Man Technologies has announced the acquisition of MedPharm (posted on Sep 12, 2019).
Most searched biographies at CSL Behring
- Paul Perreault, Chief Executive Officer and Managing Director
- Bill Mezzanotte, Executive Vice President and Head Research & Deve...
- David Lamont, Chief Financial Officer
Click on an executive to view his biography >
Other contacts in the Biotechnology industry
Latest news about CSL Behring
CSL Behring on Wikipedia, Google News & Yahoo Finance
CSL Behring on LinkedIn, Twitter & YouTube
CSL Behring has 6 subsidiaries including CSL Behring APAC, CSL Behring Austria and CSL Behring Denmark. CSL Behring has 1,315 competitors including Generation Bio (United States (USA)), Aldeyra Therapeutics (United States (USA)) and Alltech (United States (USA)). CSL Behring is owned by CSL.
Contact by email its executives including Paul Perreault 
Call CSL Behring at +1 610....
